Article - 09/12/2013 Stronger base pairing improves DNA analyses A team from the Institute of Organic Chemistry at Stuttgart University has found a chemical substitute for one of the four primary DNA building blocks, i.e. thymine. Thymine can cause problems in DNA hybridisation experiments. The thymine substitute called “E”, which stands for ethynylpyridone, binds more strongly and selectively with the adenine base on the complementary DNA strand than thymine. Highly specific DNA tests might benefit from the…https://www.gesundheitsindustrie-bw.de/en/article/news/stronger-base-pairing-improves-dna-analyses
Article - 10/03/2021 Faster to single cells using miniature grinder Tissue cells are needed for medical diagnostics, cell therapies and tissue engineering, among other things. A novel tissue grinder gently and automatically dissociates cells from tissue. In November 2020, the newly founded biotech company Fast Forward Discoveries GmbH (FFX) delivered its first tissue grinders to customers.https://www.gesundheitsindustrie-bw.de/en/article/news/faster-single-cells-using-miniature-grinder
Article - 29/11/2010 Max Rubner Institute – focusing on consumer health The research and analyses carried out by the Max Rubner Institute are aimed at protecting consumer health. The institute investigates the contamination of meat and fish and also focuses on the health benefits of food additives and the future of functional food.https://www.gesundheitsindustrie-bw.de/en/article/news/max-rubner-institute-focusing-on-consumer-health
Article - 22/03/2010 IBR Inc.: Dual strategy for safe and effective drugs IBR Inc. a science-based provider of preclinical and clinical services specialises in inflammatory diseases. The analyses it carries out for the pharmaceutical and biotech sector help exclude potential side effects of specific drug candidates early in the development process. https://www.gesundheitsindustrie-bw.de/en/article/news/ibr-inc-dual-strategy-for-safe-and-effective-drugs
Press release - 26/03/2009 5 million euros for expansion KfW Mittelstandsbank and Zukunftsfonds Heilbronn will invest 5 million euros in Tübingen-based PANATecs GmbH. PANATecs provides products and services for the pharmaceutical industry and will use the financial injection to expand and invest in modern analysis technologies such as high-mass spectrometry. https://www.gesundheitsindustrie-bw.de/en/article/press-release/5-million-euros-for-expansion
Press release - 12/12/2016 Curetis obtains EIB debt financing totaling up to EUR 25 million to further expand its diagnostic platform https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-obtains-eib-debt-financing-totaling-up-to-eur-25-million-to-further-expand-its-diagnostic-platform
Press release - 28/11/2011 CeCo Labs develops new method for isolating bacterial cell walls CeCo Labs UG, founded as a spin-off from the University of Tübingen, has developed an internationally unique method for isolating bacterial cell walls. These are used in research to investigate antibiotic resistance, for example. Unlike conventional techniques, the method developed by CeCo Labs is able to supply a very high number of ultra-pure cell walls extremely quickly. Orders have already been placed by customers across the globe.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ceco-labs-develops-new-method-for-isolating-bacterial-cell-walls
Article - 24/10/2011 BioValley Meet & Match Microfluidics, Lab-on-a-chip This year's third Meet & Match took place at the Novotel in Karlsruhe, Germany on October 20, 2011. About 12 presentations were held by representatives from different companies and universities out of the trinational BioValley: Northwest Switzerland, Alsace in France and South Baden in Germany. This Meet & Match meeting has been a great success thanks to interesting talks and a very attentive audience.https://www.gesundheitsindustrie-bw.de/en/article/news/biovalley-meet-match-microfluidics-lab-on-a-chip
Article - 05/11/2009 CLAIR provides new insights The human eye is a fascinating organ as well as model for the specialists at Stockach-based Sensovation AG. Their complex optical detection systems are based on CCD and CMOS technologies. However a high-tech sensor is able to recognise much more than many eyes put together. https://www.gesundheitsindustrie-bw.de/en/article/news/clair-provides-new-insights
Press release - 28/08/2010 Baden-Württemberg Ministry of Economic Affairs to grant ILM additional financial support The Baden-Württemberg Ministry of Economic Affairs has granted the Institute of Laser Technology in Medicine and Metrology (ILM) in Ulm additional financial support totalling 582,000 euros from the German government’s “Future Investment Programme”. The funding is to be used to renew and expand the institute’s equipment in 2010.https://www.gesundheitsindustrie-bw.de/en/article/press-release/baden-wuerttemberg-ministry-of-economic-affairs-to-grant-ilm-additional-financial-support
Press release - 13/10/2009 Trenzyme receives ISO 9001 certification The Trenzyme GmbH has set another milestone as a first class service provider for the pharma and life science industry.https://www.gesundheitsindustrie-bw.de/en/article/press-release/trenzyme-receives-iso-9001-certification
Press release - 23/07/2012 ADIRO GmbH presented chromatography learning system at ACHEMA 2012 The new learning system enables schools, higher education institutions and companies to make chromatography and the associated automation of production processes more comprehensible to pupils, students and apprentices. The modular system can be used to model chromatographic processes in detail and simulate different scenarios. The chromatography learning system was developed by ADIRO Automatisierungstechnik GmbH and the Esslingen University of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/adiro-gmbh-presented-chromatography-learning-system-at-achema-2012
Article - 07/05/2010 Günter Gauglitz: research at the boundaries of physics, chemistry and biology Biosensors and label-free optical bioanalysis are the major research priorities of Prof. Dr. Günter Gauglitz from the Institute for Physical and Theoretical Chemistry IPC at the University of Tübingen. His whole career has been about the acquisition of multi-million third-party funded projects that are worked on by a team of 15 scientists at the IPC.https://www.gesundheitsindustrie-bw.de/en/article/news/guenter-gauglitz-research-at-the-boundaries-of-physics-chemistry-and-biology
Article - 16/12/2013 Cellendes puts paradigm change in cell research to good use Cells grown on the flat furfaces of tissue culture plates do not behave as they would in their natural environment. This is why scientists are now using three-dimensional substrates to replicate the natural environmental of cells in tissue cellular matrix. Dr. Brigitte Angres and Dr. Helmut Wurst founders and managing directors of Cellendes GmbH in Reutlingen have taken advantage of this new knowledge and developed two novel hydrogels for cell…https://www.gesundheitsindustrie-bw.de/en/article/news/cellendes-puts-paradigm-change-in-cell-research-to-good-use
Press release - 11/09/2015 Venneos raises seed round of 1 million euros Venneos GmbH is based in Stuttgart and develops a novel imaging system for the analysis of biological cells. A consortium of business angels and family offices, along with the High-Tech Gründerfonds and Max Planck Society invest in the company to develop a market-ready product and prepare the market entry of the first product generation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/venneos-raises-seed-round-of-1-million-euros
Article - 19/04/2010 Natural antibodies to treat Alzheimer’s Alzheimers disease is characterised by changes in the substance and structure of the brain that are caused by the depositing of protein plaques in the brain. Prof. Michael Przybylski and his team of researchers at the University of Constance have deciphered the structure of the site where mouse antibodies attach to the plaques subsequently causing them to dissolve. These findings will now be used to identify the binding structure of a component…https://www.gesundheitsindustrie-bw.de/en/article/news/natural-antibodies-to-treat-alzheimer-s
Expert interview - 17/10/2018 Biologicals are becoming increasingly important to Boehringer Ingelheim Biopharmaceuticals are playing an increasingly important role in Boehringer Ingelheim’s development pipeline. Visible evidence of this is the company’s Biologicals Development Centre (BDC) that is currently being constructed in Boehringer Ingelheim’s Biberach plant and will bring the company’s process development under one roof by early 2020. Walter Pytlik from BIOPRO talked with Dr. Ing. Ralf Schumacher about the new centre.https://www.gesundheitsindustrie-bw.de/en/article/news/biologicals-are-becoming-increasingly-important-to-boehringer-ingelheim
Dossier - 26/03/2012 Nanobiotechnology The term nanotechnology is known by well over 50 of Germans especially since the lotus effect hit the headlines in the late 1990s. Around the turn of the millennium bio was inserted between nano and technology and nanobiotechnology has since taken up more and more room in the headlines as well as requiring major financial investment. What is nanobiotechnology what is the difference between nanotechnology and nanobiotechnology and where and what…https://www.gesundheitsindustrie-bw.de/en/article/dossier/nanobiotechnology
Press release - 12/12/2011 Insilico Biotechnology and Metabolomic Discoveries pool their expertise Insilico Biotechnology and Metabolomic Discoveries have agreed to pool their expertise to provide industrial biotech customers with a more comprehensive package of high quality services. The main focus of the cooperation lies in the field of applied systems biotechnology dealing with the metabolism of bacteria, fungi and mammalian cells. The combination of modern analytical methods with high-performance computing will give customers detailed…https://www.gesundheitsindustrie-bw.de/en/article/press-release/insilico-biotechnology-and-metabolomic-discoveries-pool-their-expertise
Article - 01/09/2011 Quality by Design – a paradigm change in bioprocess development Bioprocess technology has undergone a fundamental change with regard to the criteria used for validating product quality: around ten years ago, the U.S. Food and Drug Administration (FDA) revised the 1987 process validation guidance and the subsequent establishment of the Process Analytical Technology (PAT) initiative heralded a paradigm change in bioprocess understanding and control. The FDA’s guidance underwent a paradigm shift from what was…https://www.gesundheitsindustrie-bw.de/en/article/news/quality-by-design-a-paradigm-change-in-bioprocess-development
Article - 02/06/2014 micro-biolytics GmbH – industrial application of the AquaSpec™ technology Spectroscopic methods have been used for many decades in scientific research to obtain a wealth of information about chemical substances, substance mixtures and their reaction processes. Micro-biolytics GmbH from Esslingen have successfully developed a spectroscopic method that combines innovative technologies. The method enables the highly accurate and sensitive measurement of aqueous samples. https://www.gesundheitsindustrie-bw.de/en/article/news/micro-biolytics-gmbh-industrial-application-of-the-aquaspec-technology
Article - 16/09/2013 Infrared light as an indicator of wine quality Guaranteeing the quality of wines is becoming increasingly important so that they are able to compete in the international market. However, the quality control methods currently used are often rather time-consuming and costly. In addition, it is difficult to detect microbial grape contaminations that might jeopardise the quality of the wines. Researchers at the National Training and Research Institute for Viticulture and Horticulture in…https://www.gesundheitsindustrie-bw.de/en/article/news/infrared-light-as-an-indicator-of-wine-quality
Article - 24/09/2015 New test system for detection of HPV-related oral cavity cancers The number of people suffering from oral or oropharyngeal cancer is rising steadily. The major cause of these cancers is human papillomaviruses (HPV) that colonise the oral cavity, where they are difficult to detect. QIAGEN Lake Constance GmbH from Stockach, in cooperation with Abviris Deutschland GmbH, has developed a new test system to improve the detection of oral HPV. This new system enables rapid and reliable quantitative detection of…https://www.gesundheitsindustrie-bw.de/en/article/news/new-test-system-for-detection-of-hpv-related-oral-cavity-cancers
Article - 14/11/2011 Does cloudy apple juice prevent colon cancer? The likelihood of developing colon cancer very much depends on dietary factors. Foods and nutrients with antioxidative and anti-inflammatory properties have been found to reduce the likelihood of developing this kind of cancer. Research done by scientists from the Karlsruhe-based Max Rubner-Institut suggests that cloudy apple juice can prevent colon cancer. However, little is yet known about the molecular relationships between diet and disease.https://www.gesundheitsindustrie-bw.de/en/article/news/does-cloudy-apple-juice-prevent-colon-cancer
Article - 19/03/2012 Goal: online glucose sensor for bioreactors Microorganisms and sensitive cells that are grown in bioreactors need a well-regulated environment and a food supply in order to do what they are supposed to do: grow and produce biomass and metabolites. Many fermenters are equipped with sensors that continuously measure critical bioprocess parameters, including temperature, pH value and oxygen. Online glucose and ethanol sensors are not yet used in regulated bioreactors, even though they would…https://www.gesundheitsindustrie-bw.de/en/article/news/goal-online-glucose-sensor-for-bioreactors